Long V. Pham

1.0k total citations · 1 hit paper
23 papers, 614 citations indexed

About

Long V. Pham is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Long V. Pham has authored 23 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Hepatology and 9 papers in Epidemiology. Recurrent topics in Long V. Pham's work include SARS-CoV-2 and COVID-19 Research (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (8 papers). Long V. Pham is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (8 papers). Long V. Pham collaborates with scholars based in Denmark, South Korea and Germany. Long V. Pham's co-authors include Jens Bukh, Santseharay Ramírez, Judith M. Gottwein, Ulrik Fahnøe, Anna Offersgaard, Karen Anbro Gammeltoft, Yuyong Zhou, Carlota Fernandez-Antunez, Soon B. Hwang and Yun-Sook Lim and has published in prestigious journals such as Gastroenterology, Journal of Virology and Gut.

In The Last Decade

Long V. Pham

21 papers receiving 610 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

2022 132 citations Yuyong Zhou, Karen Anbro Gammeltoft et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Long V. Pham Denmark	13	309	188	185	141	106	23	614
Gitanjali Subramanya United States	7	438 1.4×	166 0.9×	231 1.2×	114 0.8×	62 0.6×	8	793
Anna Offersgaard Denmark	11	226 0.7×	74 0.4×	85 0.5×	94 0.7×	97 0.9×	18	406
Julie Blaising France	7	305 1.0×	108 0.6×	195 1.1×	130 0.9×	45 0.4×	8	638
Shuiyun Lan United States	12	572 1.9×	221 1.2×	264 1.4×	206 1.5×	51 0.5×	24	934
Hamed Gouklani Iran	9	196 0.6×	102 0.5×	116 0.6×	183 1.3×	52 0.5×	26	470
Ona Barauskas United States	9	244 0.8×	154 0.8×	183 1.0×	142 1.0×	37 0.3×	15	513
Annette S. Uss United States	11	100 0.3×	171 0.9×	102 0.6×	202 1.4×	38 0.4×	16	586
Djadé I. Soumana United States	8	200 0.6×	243 1.3×	150 0.8×	137 1.0×	61 0.6×	8	441
Francesco Saladini Italy	19	669 2.2×	127 0.7×	290 1.6×	252 1.8×	59 0.6×	61	1.1k
Karen Rigat United States	10	193 0.6×	363 1.9×	262 1.4×	115 0.8×	25 0.2×	13	511

Countries citing papers authored by Long V. Pham

Since Specialization

Citations

This map shows the geographic impact of Long V. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long V. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long V. Pham more than expected).

Fields of papers citing papers by Long V. Pham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long V. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long V. Pham. The network helps show where Long V. Pham may publish in the future.

Co-authorship network of co-authors of Long V. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Long V. Pham. A scholar is included among the top collaborators of Long V. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long V. Pham. Long V. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernandez-Antunez, Carlota, Line A. Ryberg, Kuan Wang, et al.. (2025). SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance. Viruses. 17(8). 1055–1055.

Walker, Melanie R., Alexander P. Underwood, Maria Rosaria Bassi, et al.. (2024). Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages. Communications Biology. 7(1). 1239–1239. 1 indexed citations

Gammeltoft, Karen Anbro, Yuyong Zhou, Line A. Ryberg, et al.. (2023). Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir. Viruses. 15(9). 1970–1970. 10 indexed citations

Offersgaard, Anna, Shan Feng, Pavel Marichal‐Gallardo, et al.. (2023). An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals. iScience. 26(2). 105949–105949. 5 indexed citations

Zhou, Yuyong, Karen Anbro Gammeltoft, Line A. Ryberg, et al.. (2022). Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system. Science Advances. 8(51). eadd7197–eadd7197. 132 indexed citations breakdown →

Pham, Long V., Rodrigo Velázquez‐Moctezuma, Ulrik Fahnøe, et al.. (2022). Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization. Viruses. 14(11). 2527–2527. 2 indexed citations

Fahnøe, Ulrik, Long V. Pham, Carlota Fernandez-Antunez, et al.. (2022). Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication. Viruses. 14(2). 172–172. 24 indexed citations

Ramírez, Santseharay, Carlota Fernandez-Antunez, Andrea Galli, et al.. (2021). Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication. Antimicrobial Agents and Chemotherapy. 65(7). e0009721–e0009721. 63 indexed citations

Gammeltoft, Karen Anbro, Yuyong Zhou, Andrea Galli, et al.. (2021). Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro. Antimicrobial Agents and Chemotherapy. 65(9). e0268020–e0268020. 37 indexed citations

10.

Pham, Long V., Martin Schou Pedersen, Ulrik Fahnøe, et al.. (2021). HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4. Gut. 71(3). 627–642. 9 indexed citations

11.

Zhou, Yuyong, Kerry Gilmore, Santseharay Ramírez, et al.. (2021). In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. Scientific Reports. 11(1). 14571–14571. 70 indexed citations

12.

Pham, Long V., Sanne B. Jensen, Ulrik Fahnøe, et al.. (2018). HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape. Journal of Hepatology. 70(3). 388–397. 32 indexed citations

13.

Pham, Long V., Santseharay Ramírez, Judith M. Gottwein, et al.. (2018). HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models. Gastroenterology. 154(8). 2194–2208.e12. 37 indexed citations

14.

Pham, Long V., et al.. (2017). Rad51 Interacts with Non-structural 3 Protein of Hepatitis C Virus and Regulates Viral Production. Frontiers in Microbiology. 8. 1249–1249. 5 indexed citations

15.

Gottwein, Judith M., Long V. Pham, Lotte S. Mikkelsen, et al.. (2017). Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1–7 and Escape Variants. Gastroenterology. 154(5). 1435–1448. 62 indexed citations

16.

Pham, Long V., Santseharay Ramírez, Thomas H. R. Carlsen, et al.. (2017). Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors. Antimicrobial Agents and Chemotherapy. 61(6). 9 indexed citations

17.

Li, Yi‐Ping, Long V. Pham, Nathalie Y. Uzcátegui, & Jens Bukh. (2016). Functional analysis of microRNA-122 binding sequences of hepatitis C virus and identification of variants with high resistance against a specific antagomir. Journal of General Virology. 97(6). 1381–1394. 18 indexed citations

18.

Nguyen, Lam, Yun-Sook Lim, Long V. Pham, et al.. (2014). Stearoyl Coenzyme A Desaturase 1 Is Associated with Hepatitis C Virus Replication Complex and Regulates Viral Replication. Journal of Virology. 88(21). 12311–12325. 40 indexed citations

19.

Pham, Long V., et al.. (2013). Modulation of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 by Hepatitis C Virus Core Protein. Journal of Virology. 87(10). 5718–5731. 20 indexed citations

20.

Pham, Long V., et al.. (2012). Hepatitis C virus non-structural 5B protein interacts with cyclin A2 and regulates viral propagation. Journal of Hepatology. 57(5). 960–966. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact